Figure 4
Effect of dalbavancin treatment Rabbits of the OP group were subject to Staphylococcus aureus osteomyelitis followed three weeks later by E. coli pyelonephritis; rabbits of the ODP group were subject to Staphylococcus aureus osteomyelitis, three weeks later received one single intravenous infusion of dalbavancin and one week later were subject to E. coli pyelonephritis (A) TNFα responses to bacterial lipopolysaccharide (LPS) of isolated peripheral blood mononuclear cells; and (B) comparative tissue myeloperoxidase activity. The p values of differences are provided.
